[144] Veris Residential, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Veris Residential, Inc. (VRE) reporting a proposed sale of 85,920 common shares through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $1,378,491.89. The filer shows those shares were acquired in October 2018 via open-market purchases (57,787 shares on 10/16/2018 and 28,133 shares on 10/15/2018) paid in cash. The filing also lists sales by related entities within the past three months: 64,080 shares (gross proceeds $1,032,924.74) and 85,920 shares (gross proceeds $1,384,970.29) on 09/09/2025. The filer certifies no undisclosed material adverse information and includes the standard signature and legal attestation language.

Insights

Securities/Financial Analyst

TL;DR: Routine insider/affiliate sale notice; transaction size is small relative to outstanding shares and appears procedural.

The Form 144 documents a proposed sale of 85,920 common shares valued at approximately $1.38 million, executed via a broker on the NYSE. Acquisition dates in 2018 and cash payment indicate these are long-held shares rather than recent grants. Recent related entity sales on 09/09/2025 are disclosed with gross proceeds, suggesting coordinated disposition activity but not necessarily material to capital structure given the 93,421,769 shares outstanding figure reported here. No earnings, covenant, or liquidity details are provided in this filing.

Compliance / Corporate Governance Analyst

TL;DR: Filing follows Rule 144 disclosure conventions; attestation and broker details are present, with no red flags in form content.

The notice includes necessary elements: broker name and address, exact share counts, acquisition dates and methods, and recent sales by affiliated entities. The signer affirms absence of undisclosed material adverse information and includes standard criminal-statute warning. The filing does not provide any indication of undisclosed events or deviations from Rule 144 requirements; further context (e.g., insider role, affiliation specifics) is not included in this document.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	85920	1378491.89	93421769	09/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/12/2018	Open Market Purchase	Open Market			57787	10/16/2018	Cash
Common	10/11/2018	Open Market Purchase	Open Market			28133	10/15/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	64080	1032924.74
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	85920	1384970.29

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Veris Residential (VRE) disclose?

The form discloses a proposed sale of 85,920 common shares via Morgan Stanley Smith Barney on the NYSE, valued at $1,378,491.89.

When were the shares being sold originally acquired?

The shares were acquired in open-market purchases on 10/11/2018 and 10/12/2018, with settlement dates in October 2018 and paid in cash.

Are there recent related sales by affiliated entities?

Yes. The filing lists two sales on 09/09/2025: 64,080 shares for $1,032,924.74 and 85,920 shares for $1,384,970.29 by affiliated entities.

How large is the proposed sale relative to outstanding shares?

The filing shows 93,421,769 shares outstanding; the proposed 85,920-share sale represents a small fraction of total outstanding shares.

Does the filer assert any undisclosed material information?

The filer signs the notice representing they do not know of any material adverse information about the issuer that has not been publicly disclosed.